BNET Industries

CollaGenex Pharmaceuticals Inc.

(CGPI) is in the Pharma Industry

Last Fiscal Year Sales:$63.5M
  • Public
  • US
Dow Jones Description

CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company currently focused on developing and marketing proprietary, innovative medical therapies to the dermatology market. CollaGenex's has a highly-experienced 80-person sales force that is targeting 5,600 dermatologists. In July 2006, CollaGenex launched Oracea (doxycyline, USP) Capsules 40 mg*, the first FDA-approved systemic product for the treatment of rosacea. The Company also markets Alcortin (1% iodoquinol and 2% hydrocortisone), a prescription topical antifungal steroid combination, and Novacort (2% hydrocortisone acetate and 1% pramoxine HCl), a prescription topical steroid and anesthetic. Alcortin and Novacort are marketed by the Company under a Promotion and Cooperation agreement with Primus Pharmaceuticals, Inc. The Company has a pipeline of innovative product candidates with possible applications in dermatology and other disease states. CollaGenex is conducting Phase II clinical trials to evaluate COL-118, a topical compound based on the SansRosa technology, for the treatment of redness associated with rosacea. CollaGenex recently acquired the rights to develop and commercialize becocalcidiol, a patented Vitamin D analogue developed by QuatRx Pharmaceuticals Company, and it is currently in Phase II clinical trials for the topical treatment of mild to moderate psoriasis. CollaGenex plans to leverage its technology platforms to develop a range of topical dermatological products with enhanced...

President, Chief Executive Officer and Director
Colin W. Stewart
Number of Employees 147
Contact Information

41 University Dr

Newtown, Pennsylvania 18940-1873

www.collagenex....

(215) 579-7388

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Cornerstone Therapeutics Appoints General Counsel

    11/13/09 - Merger / Acquisition - View Story

  • CollaGenex Pharmaceuticals Announces Agreement...

    8/20/09 - Merger / Acquisition - View Story

  • CollaGenex Pharmaceuticals Appoints...

    7/29/09 - Mgmt. Change Entering - Vice President - View Story

News & Analysis

collagenex pharmaceuticals inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Colin W. Stewart President, Chief Executive Officer and Director
Albert Draaijer President of Galderma's Operations
Klaus P.J. Theobald Senior Vice President & Chief Medical Officer
Nancy C. Broadbent CFO and Treasurer
Dave Pfeiffer Senior Vice President, Sales and Marketing
Andrew K.W. Powell Vice President, General Counsel and Secretary
Gregory Ford Vice President, Business Development and Strategic Planning
Gregory Ford James Vice President, Business Development
Kenneth William Powell Andrew Vice President, G. Counsel and Corp. Secretary.
James E. Daverman General Partner
Robert C. Black Director
Robert J. Easton Director
Stephen Kaplan Director
William J. O'Shea Director

Board of Directors

Name (plus bio) Position
Peter R. Barnett Audit Committee Chairman
Robert A. Beardsley Board of Directors
W James Shea Board of Directors
W. James O'Shea Board of Directors

Mr. Stewart joined CollaGenex in December 2003 as President and Chief Executive Officer and has been a member of our Board of Directors since December 2003. From October 1998 until joining CollaGenex, Mr. Stewart served as the president and chief executive officer of Muro Pharmaceutical, Inc., a pharmaceutical manufacturer and distributor. From 1988 to 1998, Mr. Stewart was employed by the ASTA Medica Group in a number of sales, marketing and general management positions of increasing responsibility. Prior to 1988, Mr. Stewart was employed by Sterling-Winthrop, Ltd., a United Kingdom pharmaceutical company, for 13 years in sales and general management.

Organization Position Status
CollaGenex Pharmaceuticals, Inc. President, Chief Executive Officer and Director Current
Comerica Bank Counsel Former
CollaGenex Pharmaceuticals, Inc. Board of Directors Former

Organization Position Status
CollaGenex Pharmaceuticals, Inc. President of Galderma's Operations Current

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Senior Vice President & Chief Medical Officer Current

Organization Position Status
CollaGenex Pharmaceuticals, Inc. CFO and Treasurer Current
CollaGenex Pharmaceuticals, Inc. Board of Directors Current
Cangene Corporation chief financial officer Former
Human Genome Sciences, Inc. Officer Former
Cangene Corporation Officer Former

Mr. Pfeiffer has over 20 years of experience in the pharmaceutical industry. Prior to Nitric Bio, he was the Sr. VP of Sales and Marketing at CollaGenex Pharmaceuticals, where he was responsible for all commercial activities. CollaGenex was sold to Galderma Laboratories Inc. in April, 2008. Mr. Pfeiffer joined CollaGenex in June 1997 as Vice President, Marketing and was promoted to Senior Vice President, Sales and Marketing in December 2000. From September 1995 until June 1997, Mr. Pfeiffer served as Director of Marketing, Health Management Services for SmithKline Beecham. Before that he held a number of marketing and sales positions at Zeneca and Lederle Laboratories.

Organization Position Status
Nitric Bio, Inc. Chief Operating Officer Current
CollaGenex Pharmaceuticals, Inc. Senior Vice President, Sales and Marketing Current
GlaxoSmithKline Plc director of marketing Former
SmithKline Beecham Corporation Director of Marketing Former

Mr. Powell joined the company in September 2004 from Baxter International Inc., a global healthcare and biotechnology company. He brings nearly 20 years of legal experience, including 15 years in the healthcare industry. At Baxter he held various leadership positions in the company's bioscience, international and European businesses. Prior to becoming involved in the healthcare industry, Mr. Powell worked in securities and corporate finance with Gibson, Dunn & Crutcher in Washington D.C., and in the U.K. with Guiness Mahon and Co. Mr. Powell is a graduate of the University of North Carolina at Chapel Hill and Stanford Law School.

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Vice President, General Counsel and Secretary Current
Bioleap Current
CollaGenex Pharmaceuticals, Inc. General Counsel Former
Gibson, Dunn & Crutcher LLP Former
Baxter International Inc. Former
The University of North Carolina at Chapel Hill Former

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Vice President, Business Development and Strategic Planning Current

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Vice President, Business Development Current

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Vice President, G. Counsel and Corp. Secretary. Current

Organization Position Status
Granville Baird Capital Partners Limited Operating Partner & Advisory Board Chairman Current
CollaGenex Pharmaceuticals, Inc. General Partner Current
Baird Asia Limited Operating Partner & Advisory Board Chairman Current
Marshall Erdman & Associates, Inc. Chairman of the Board Current
CollaGenex Pharmaceuticals, Inc. Board of Directors Current
Marquette Venture Partners Co-Founder Former
Marquette Venture Partners Managing General Partner Former
Wharton School, University of Pennsylvania Former
CollaGenex Pharmaceuticals, Inc. Chairman of the Board Managing General Partner, Redfish Partners Lp Former
Wharton Graduate School of the University of Pennsylvania MBA Degree Former
University of Michigan Former

Organization Position Status
Star Ranch Dental Spa President Current
Star Ranch Dental Spa Owner Current
CollaGenex Pharmaceuticals, Inc. Audit Committee Chairman Current
American Dental Association Board of Directors Current
American Dental Association Active Member Current
University of Pennsylvania Chief Executive Officer Former
Pearle Vision, Inc. president Former
CollaGenex Pharmaceuticals, Inc. President, Star Ranch Dental Spa Former
United Dental Care, Inc. President Former
United Dental Care, Inc. previously chief operations officer Former
CollaGenex Pharmaceuticals, Inc. Director Former
University of Pennsylvania School of Dental Medicine Former

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Board of Directors Current
Strategic News Service LLC Board of Directors Current
Kempharm, Inc. Board of Directors Current
Bioseek, Inc. Board of Directors Current
CollaGenex Pharmaceuticals, Inc. President and Chief Executive Officer, Kereos, Inc. Former
Kereos, Inc. Chief Executive Officer Former
Kereos, Inc. president Former
University of Chicago M.B.A. in Finance Former

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Director Current
AstraZeneca PLC president Former
Zeneca Vice President Former

Organization Position Status
Easton & Associates Co-Founder Current
Scisive Consulting LP Founder Current
Scisive Consulting LP Chairman Current
CollaGenex Pharmaceuticals, Inc. Director Current
Cepheid Director Current
The Wilkerson Group Co-Founder Former
The Wilkerson Group Senior Officer Former
Union Carbide Corporation Former
Easton & Associates Chairman Former
CollaGenex Pharmaceuticals, Inc. Chairman, Easton Associates, Llc Former
Cepheid Dean O. Morton, Chair Former
Rice University Degrees In Chemical Engineering Former

Stephen A. Kaplan has served as a director of the Company since May 2001. Since 1995, Mr. Kaplan has been a principal and portfolio manager of Oaktree Capital Management, LLC, a private investment management firm, where he co-manages Oaktree's Principal Activities Group which invests in majority and significant minority positions in both private and public companies. From 1993 to 1995, Mr. Kaplan was a Managing Director of Trust Company of the West. Prior to joining the Trust Company of the West, Mr. Kaplan was a partner of the law firm of Gibson, Dunn & Crutcher. Mr. Kaplan currently serves as a director of Regal Entertainment Group, a company listed on the New York Stock Exchange, Genco Shipping & Trading Limited, a company listed on the New York Stock Exchange and numerous private companies.

Organization Position Status
Oaktree Capital Management, LLC Portfolio Manager Current
Capital Management, Inc. Principal Current
Dungeons and Dreamers Director Current
Genco Shipping & Trading Limited Director Current
General Maritime Corporation Board of Directors Current
Cannery Casino Resorts, LLC Director Current
Alliance Imaging, Inc. Director Current
CollaGenex Pharmaceuticals, Inc. Director Current
Oaktree Capital Management, LLC Board of Directors Current
Regal Entertainment, Inc. Director Current
National Cinemedia, LLC Director Current
Regal Entertainment Group Director Current
Edwars Theaters, Inc Director Current
Lineage Power OEM Division Director Current
Forest Oil Corporation Director Current
HydroChem Industrial Services, Inc. Director Current
Trust Company of the West Managing Director Former
Gibson, Dunn & Crutcher LLP Partner Former
Gibson, Dunn & Crutcher LLP Attorney Former
Oaktree Capital Management, LLC Principal Former
New York University School of Law J.D Former
The State University of New York B.S. degree Former

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Board of Directors Current
Surface Logix, Inc. Board of Directors Current

W. James O'Shea has served as a member of our Board of Directors since June 2007. From October 1999 to March 2007 Mr. O'Shea was President and Chief Operating Officer at Sepracor where he was responsible for successfully building that organization's commercial infrastructure. From April to August 2007, Mr. O'Shea served as Sepracor's Vice Chairman. Prior to Sepracor, Mr. O'Shea was Senior Vice President of Sales and Marketing and Medical Affairs for Zeneca Pharmaceuticals, a business unit of Zeneca Inc. While at Zeneca, he also held several management positions of increasing responsibility in international sales and marketing in the U.S. and U.K. Mr. O'Shea is an Executive Board member and past Chairman of the National Pharmaceutical Council and is also a Board member of Surface Logix, Inc. Mr. O'Shea is a graduate of Liverpool Lord Byron University. He received an honors degree in applied physics from the Institute of Physics.

Organization Position Status
CombinatoRx, Incorporated Class III Director Current
Charley's Fund, Inc. Chairman Current
CombinatoRx, Incorporated Chairman Current
Foundation Medical Partners L.P. Chairman Current
CollaGenex Pharmaceuticals, Inc. Board of Directors Current
Surface Logix, Inc. Board Member Current
National Pharmaceutical Council Executive Board Member Current
Global Life Science Ventures AG Vice Chairman, Sepracor Inc. Current
Sepracor Inc. President Former
CollaGenex Pharmaceuticals, Inc. President and Chief Operating Officer, Sepracor, Inc. Former
Sepracor Inc. Chief Operating Officer Former
National Pharmaceutical Council Chairman Former
CollaGenex Pharmaceuticals, Inc. Chairman Former
Sepracor Inc. Vice Chairman Former
Institute of Physics Degree In Applied Physics Former

Organization Position Status
CollaGenex Pharmaceuticals, Inc. Director Current
Surface Logix, Inc. Director Current
Sepracor Inc. President Former
Sepracor Inc. Coo Former
National Pharmaceutical Council Chairman Former
National Pharmaceutical Council Executive Board Member Former

Executive News

  • CollaGenex Pharmaceuticals Announces Agreement...

    Citybizlist - 8/20/09 - View Story

advertisement
IndustryTop Rated
advertisement